High feasibility and safety of office-based transurethral laser ablation for recurrent non-muscle invasive bladder cancer: a single-center experience.

Zimak Z, Vidovic D, Kulis T, Hauptman D, Hudolin T, Bakula M, Kastelan Z

Open source

DOI
10.3389/fonc.2026.1683009
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1683009,
  title = {High feasibility and safety of office-based transurethral laser ablation for recurrent non-muscle invasive bladder cancer: a single-center experience.},
  author = {Zimak Z and Vidovic D and Kulis T and Hauptman D and Hudolin T and Bakula M and Kastelan Z},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1683009},
  url = {https://doi.org/10.3389/fonc.2026.1683009}
}

RIS

TY  - JOUR
TI  - High feasibility and safety of office-based transurethral laser ablation for recurrent non-muscle invasive bladder cancer: a single-center experience.
AU  - Zimak Z
AU  - Vidovic D
AU  - Kulis T
AU  - Hauptman D
AU  - Hudolin T
AU  - Bakula M
AU  - Kastelan Z
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1683009
UR  - https://doi.org/10.3389/fonc.2026.1683009
ER  - 

APA

Z, Z., D, V., T, K., D, H., T, H., M, B., & Z, K. (2026). High feasibility and safety of office-based transurethral laser ablation for recurrent non-muscle invasive bladder cancer: a single-center experience.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1683009

Source records